US$ 26.26
most effective glp-1 for obesity treatment 2025 Impact: How GLP-1s Are Changing the Diabetes Paradigm World Health Organization issues first-ever
Description
[DOI] [PubMed] [Google Scholar] 84.Norton K, Norton L, Sadgrove D

Reference: Addressing the risk of ocular complications of GLP-1RAs

Semaglutide (Ozempic, Wegovy): a GLP-1 receptor agonist which targets the GLP-1 receptor specifically 2
While these medications are not primarily classified as hormonal therapies, their metabolic effects inevitably intersect with endocrine function, particularly in patients with obesity and insulin resistanceconditions known to disrupt multiple hormonal axes

doi:10.1016/S2213-8587(25)00092-0
